INTERCEPT PHARMACEUTICALS IN ICPT 3.25 07.01.23
NOTE 3.250% 7/0 · US DOMESTIC · CUSIP 45845PAA6
4
institutional holders
-14 vs Q1 2023
13.0k
shares reported held*
$10.1mreported value*
1 new
0 added
1 reduced
15 sold out
net sold ≈ $87.7m (+10.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $777.62.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 21 |
| Q4 2022 | 23 |
| Q1 2023 | 18 |
| Q2 2023 | 4 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 8 | 5 |
| Q1 2023 | 7 | 6 |
| Q2 2023 | 1 | 16 |
Biggest buyers
| CW Advisors, LLC | New | +10.0k |
Biggest sellers
| DEERFIELD MANAGEMENT COMPANY, L.P. | Sold out | -57.8m |
| Kohlberg Kravis Roberts & Co. L.P. | Sold out | -13.5m |
| OAKTREE CAPITAL MANAGEMENT LP | Reduced | -4.7m |
| Atlas Merchant Capital LLC | Sold out | -3.5m |
| Russell Investments Group, Ltd. | Sold out | -3.4m |
| MORGAN STANLEY | Sold out | -1.5m |
| PIPER SANDLER & CO. | Sold out | -1.2m |
| WELLS FARGO & COMPANY/MN | Sold out | -550.5k |
| STATE STREET CORP | Sold out | -521.0k |
| GAMCO INVESTORS, INC. ET AL | Sold out | -250.0k |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| OAKTREE CAPITAL MANAGEMENT LP 0.13% of their portfolio | 9.5m $9.6m | Reduced -4.7m |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.00% of their portfolio | 200.0k $198.5k | Unchanged |
| CW Advisors, LLC 0.00% of their portfolio | 10.0k $10.0k | New |
| WEDBUSH SECURITIES INC 0.01% of their portfolio | 3.0k $300.0k | Unchanged |